Drug Trial Radar · NCT03089944
A Study of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults With Chronic Hepatitis C Virus (HCV) Genotype 1-6 Infection and Compensated Cirrhosis
Last checked: Nov 20, 2026Latest source record: Jul 13, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
343
Actual
Start
Apr 28, 2017
Primary completion
Jul 31, 2019
Study completion Nov 8, 2019
Sponsor
- Lead sponsor
- AbbVieAbbVie (ABBV)
- Sponsor type
- Industry
- First posted
- Mar 24, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Phase 3b, single arm, open-label, multicenter study in treatment naïve adults with chronic HCV infection and compensated cirrhosis to assess the safety of 8 weeks of treatment with glecaprevir/pibrentasvir and to demonstrate the efficacy of the sustained virologic response 12 weeks post dosing (SVR12) rates of 8 weeks of treatment with glecaprevir/pibrentasvir compared to the historical SVR12 rates of 12 weeks of treatment with glecaprevir/pibrentasvir.
Conditions
- Hepatitis C Virus (HCV)
Interventions
Glecaprevir/PibrentasvirDrug
Tablet
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Sustained Virologic Response 12 Weeks Post-treatment (SVR12) in Hepatitis C Virus (HCV) Genotype (GT) 1,2,4,5 and 6-infected Participants in the Per Protocol (PP) PopulationTime frame: 12 weeks after last dose of study drug
- Percentage of Participants With SVR12 in HCV GT 1,2,4,5 and 6-infected Participants in the Intent-To-Treat (ITT) PopulationTime frame: 12 weeks after last dose of study drug
Locations
113 sites in 19 countries. Site status is shown where the registry gives one.
St. Josephs Hosp and Med Ctr /ID# 162762
Phoenix, Arizona
Mayo Clinic Arizona /ID# 162314
Phoenix, Arizona
Liver Wellness Center /ID# 162244
Little Rock, Arkansas
Felizarta /ID# 162295
Bakersfield, California
VA Long Beach Healthcare System /ID# 162298
Long Beach, California
Usc /Id# 162248
Los Angeles, California
Kaiser Permanente - San Diego (Palm Ave) /ID# 162289
San Diego, California
Stanford University School of Med /ID# 162209
Stanford, California
Cedars-Sinai Medical Center - West Hollywood /ID# 162313
West Hollywood, California
University of Miami /ID# 162210
Miami, Florida
Triple O Research Institute /ID# 162300
West Palm Beach, Florida
Piedmont Hospital /ID# 162646
Atlanta, Georgia
Northwestern University Feinberg School of Medicine /ID# 162208
Chicago, Illinois
Unity Point Health /ID# 162247
Des Moines, Iowa
The University of Iowa Hospita /ID# 162214
Iowa City, Iowa
University of Louisville /ID# 162242
Louisville, Kentucky
Louisiana Research Ctr. LLC /ID# 162567
Shreveport, Louisiana
Mercy Medical Center /ID# 162291
Baltimore, Maryland
Mayo Clinic - Rochester /ID# 162251
Rochester, Minnesota
Southern Therapy and Advanced Research (STAR) LLC /ID# 162241
Jackson, Mississippi
CHI Health Alegent Creighton /ID# 162286
Omaha, Nebraska
Univ Nebraska Med Ctr /ID# 162285
Omaha, Nebraska
Rnjms /Id# 162213
Newark, New Jersey
Weill Cornell Medical College /ID# 161051
New York, New York
Icahn School of Med Mt. Sinai /ID# 162294
New York, New York
Montefiore Medical Center /ID# 162312
The Bronx, New York
James J. Peters VA Medical Center /ID# 162644
The Bronx, New York
Duke University Medical Center /ID# 162299
Durham, North Carolina
Cumberland Research Assoc /ID# 162212
Fayetteville, North Carolina
Carolinas Center for Liver Dis /ID# 162569
Statesville, North Carolina
University Hospitals Cleveland /ID# 162243
Cleveland, Ohio
Cleveland Clinic /ID# 162570
Cleveland, Ohio
Osuchs /Id# 162284
Tulsa, Oklahoma
Lehigh Valley Health Network /ID# 162603
Allentown, Pennsylvania
Center for Liver Diseases, Oakland /ID# 162568
Pittsburgh, Pennsylvania
Vanderbilt Univ Med Ctr /ID# 162211
Nashville, Tennessee
Texas Digestive Disease Consul /ID# 162648
Dallas, Texas
University of Texas Health /ID# 162288
Houston, Texas
Virginia Commonwealth Univ /ID# 162215
Richmond, Virginia
Univ of Wisconsin Hosp/Clinics /ID# 162645
Madison, Wisconsin
Showing 40 of 113 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.